Wang Gexin, Thompson Scott M
Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
J Neurosci. 2008 Nov 12;28(46):11959-69. doi: 10.1523/JNEUROSCI.3296-08.2008.
Central pain syndrome (CPS) is defined as pain associated with a lesion of the CNS and is a common consequence of spinal cord injuries. We generated a rodent model of CPS by making unilateral electrolytic or demyelinating lesions centered on the spinothalamic tract in rats. Thermal hyperalgesia and mechanical allodynia occurred in both hind paws and forepaws by 7 d postlesion and were maintained >31 d. Field potentials in the ventral posterior lateral nucleus (VPL) in thalamic brain slices from lesioned animals displayed an increased probability of burst responses. Ethosuximide, a T-type calcium channel blocker, eliminated busting in lesioned thalamic slices and attenuated lesion-induced hyperalgesia and allodynia. We conclude that CPS in this model results from an increase in the excitability of thalamic nuclei that have lost normal ascending inputs as the result of a spinal cord injury and suggest that ethosuximide will relieve human CPS by restoring normal thalamic excitability.
中枢性疼痛综合征(CPS)被定义为与中枢神经系统(CNS)损伤相关的疼痛,是脊髓损伤的常见后果。我们通过在大鼠中制作以脊髓丘脑束为中心的单侧电解或脱髓鞘损伤,建立了CPS的啮齿动物模型。损伤后7天,双侧后爪和前爪均出现热痛觉过敏和机械性异常性疼痛,并持续超过31天。来自损伤动物的丘脑脑片腹后外侧核(VPL)的场电位显示爆发反应的概率增加。乙琥胺,一种T型钙通道阻滞剂,消除了损伤丘脑切片中的爆发,并减轻了损伤诱导的痛觉过敏和异常性疼痛。我们得出结论,该模型中的CPS是由于脊髓损伤导致丘脑核团失去正常上行输入后兴奋性增加所致,并表明乙琥胺将通过恢复正常丘脑兴奋性来缓解人类CPS。